Green Planet Bio Engineering (GPLB) Free Cash Flow Growth (3y) (2021 - 2026)
Green Planet Bio Engineering (GPLB) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | - |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | - |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | - |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | - |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | - |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | - |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | - |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | - |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | - |
| 10 | Green Planet Bio Engineering | 200,064.02 | 200,064.02 | - | -6.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.87% |
| Mar 31, 2026 | -11.52% |
| Dec 31, 2025 | -30.64% |
| Sep 30, 2025 | -4.31% |
| Jun 30, 2025 | 25.18% |
| Mar 31, 2025 | -13.66% |
| Dec 31, 2024 | -13.43% |
| Sep 30, 2024 | 23.80% |
| Jun 30, 2024 | 7.11% |
| Dec 31, 2023 | -42.68% |
| Sep 30, 2023 | 17.73% |
| Jun 30, 2023 | -116.97% |
| Mar 31, 2023 | 6.23% |
| Dec 31, 2022 | -0.45% |
| Sep 30, 2022 | 21.41% |
| Jun 30, 2022 | -33.39% |
| Mar 31, 2022 | 25.45% |
| Dec 31, 2021 | 42.28% |